Literature DB >> 18347194

Toll-like receptor 4 mediates an antitumor host response induced by Salmonella choleraesuis.

Che-Hsin Lee1, Chao-Liang Wu, Ai-Li Shiau.   

Abstract

PURPOSE: We have shown tumor-targeting and antitumor activities of an attenuated Salmonella choleraesuis in various tumor models. Meanwhile, host factors, including innate and adaptive immune responses, play roles in Salmonella-induced antitumor activity. Toll-like receptor 4 (TLR4) is identified as a signaling receptor for lipopolysaccharide derived from Gram-negative bacteria. However, the detailed mechanism of the S. choleraesuis-induced antitumor immune response via TLR4 remained uncertain. EXPERIMENTAL
DESIGN: Herein, we used wild-type C3H/HeN mice and TLR4-deficient C3H/HeJ mice to study the role of TLR4 in the antitumor immune responses induced by S. choleraesuis.
RESULTS: The amounts of S. choleraesuis were cleared more rapidly from the normal organs in C3H/HeN mice than those in C3H/HeJ mice. Tumors in C3H/HeN mice treated with S. choleraesuis were significantly smaller than those treated with PBS. By contrast, in TLR4-deficient mice, there was a slight difference in inhibition of tumor growth. Meanwhile, we found that S. choleraesuis significantly up-regulated IFN-gamma, IFN-inducible chemokines CXCL9 (MIG), and CXCL10 (IP-10) productions in C3H/HeN mice, but not in C3H/HeJ mice. Furthermore, immunohistochemical staining of the tumors revealed less intratumoral microvessel density, more infiltration of macrophages, neutrophils, CD4(+) and CD8(+) T cells, and cell death in C3H/HeN mice after S. choleraesuis treatment compared with those in C3H/HeJ mice. The interaction between TLR4 and S. choleraesuis seemed to polarize the T-cell response to a T helper 1-dominant state.
CONCLUSIONS: These results suggest TLR4 may play an important role in the molecular mechanism of S. choleraesuis-induced host antitumor responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347194     DOI: 10.1158/1078-0432.CCR-07-2050

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  32 in total

Review 1.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

2.  In vitro and in vivo anticancer activity of a synthetic glycolipid as Toll-like receptor 4 (TLR4) activator.

Authors:  Yong-Shiang Lin; Li-De Huang; Chao-Hsiung Lin; Po-Hsiung Huang; Yu-Jen Chen; Fen-Hwa Wong; Chun-Cheng Lin; Shu-Ling Fu
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

3.  Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.

Authors:  Suman Kundu; Keke Fan; Mingli Cao; Daniel J Lindner; Zhizhaung Joe Zhao; Ernest Borden; Taolin Yi
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

4.  Bacteriolytic therapy of experimental pancreatic carcinoma.

Authors:  Claudia Maletzki; Michael Gock; Ulrike Klier; Ernst Klar; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

5.  Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.

Authors:  Ai-Li Shiau; Min-Li Teo; Shin-Yao Chen; Chrong-Reen Wang; Jeng-Long Hsieh; Meng-Ya Chang; Chih-Jui Chang; Julie Chao; Lee Chao; Chao-Liang Wu; Che-Hsin Lee
Journal:  BMC Cancer       Date:  2010-05-31       Impact factor: 4.430

Review 6.  Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management.

Authors:  Guoying Ni; Tianfang Wang; Lin Yang; Yuejian Wang; Xiaosong Liu; Ming Q Wei
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 7.  Potential therapeutic anti-tumor effect of a Salmonella-based vaccine.

Authors:  Sun-Young Chang; Yeon-Jeong Kim; Hyun-Jeong Ko
Journal:  Hum Vaccin Immunother       Date:  2013-06-03       Impact factor: 3.452

8.  Zhankuic acid A isolated from Taiwanofungus camphoratus is a novel selective TLR4/MD-2 antagonist with anti-inflammatory properties.

Authors:  Yu-Fon Chen; Ai-Li Shiau; Sheng-Hung Wang; Jai-Sing Yang; Sue-Joan Chang; Chao-Liang Wu; Tian-Shung Wu
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

9.  Salmonella enterica serovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect.

Authors:  Sofía Grille; María Moreno; Thais Bascuas; Juan M Marqués; Natalia Muñoz; Daniela Lens; Jose A Chabalgoity
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

10.  Early immune response following Salmonella enterica subspecies enterica serovar Typhimurium infection in porcine jejunal gut loops.

Authors:  François Meurens; Mustapha Berri; Gael Auray; Sandrine Melo; Benoît Levast; Isabelle Virlogeux-Payant; Claire Chevaleyre; Volker Gerdts; Henri Salmon
Journal:  Vet Res       Date:  2008-10-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.